Nov 11, 2016 6:30 am EST VolitionRx Limited to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016
Nov 10, 2016 6:30 am EST VolitionRx Limited Announces Third Quarter 2016 Financial Results and Business Update
Nov 4, 2016 6:30 am EDT VolitionRx Limited Schedules Third Quarter 2016 Earnings Conference Call and Business Update
Nov 3, 2016 6:30 am EDT VolitionRx Limited and Hvidovre Hospital Begin Large Prospective Clinical Study
Oct 26, 2016 6:30 am EDT VolitionRx Limited Announces Acquisition of New Belgian Facility and Appointment of COO to Belgian Volition
Oct 21, 2016 11:34 am EDT VolitionRx Limited Announces Exercise of Over-Allotment Option by Underwriter
Oct 17, 2016 6:30 am EDT Triage Blood Test Data Presented to Leading International Experts at the World Endoscopy Organization's Colorectal Cancer Screening Committee
Oct 11, 2016 8:30 am EDT Data Presented at ESMO 2016 Demonstrates that VolitionRx Limited's Novel Blood Test for Colorectal Cancer Potentially Reduces the Need for Colonoscopy Referral by 25%